NEXGEL INC (NXGL) Stock Fundamental Analysis

NASDAQ:NXGL • US65344E1073

1.3 USD
-0.01 (-0.76%)
Last: Feb 13, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NXGL. NXGL was compared to 185 industry peers in the Health Care Equipment & Supplies industry. NXGL may be in some trouble as it scores bad on both profitability and health. NXGL is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • NXGL had negative earnings in the past year.
  • NXGL had a negative operating cash flow in the past year.
  • In the past 5 years NXGL always reported negative net income.
  • In the past 5 years NXGL always reported negative operating cash flow.
NXGL Yearly Net Income VS EBIT VS OCF VS FCFNXGL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M

1.2 Ratios

  • The Return On Assets of NXGL (-24.78%) is comparable to the rest of the industry.
  • NXGL's Return On Equity of -55.53% is in line compared to the rest of the industry. NXGL outperforms 49.19% of its industry peers.
Industry RankSector Rank
ROA -24.78%
ROE -55.53%
ROIC N/A
ROA(3y)-35.81%
ROA(5y)-46.56%
ROE(3y)-62.13%
ROE(5y)-690.12%
ROIC(3y)N/A
ROIC(5y)N/A
NXGL Yearly ROA, ROE, ROICNXGL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K

1.3 Margins

  • With a Gross Margin value of 38.30%, NXGL is not doing good in the industry: 68.65% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of NXGL has grown nicely.
  • NXGL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y266%
GM growth 5YN/A
NXGL Yearly Profit, Operating, Gross MarginsNXGL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • NXGL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NXGL has been increased compared to 1 year ago.
  • The number of shares outstanding for NXGL has been increased compared to 5 years ago.
  • NXGL has a worse debt/assets ratio than last year.
NXGL Yearly Shares OutstandingNXGL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
NXGL Yearly Total Debt VS Total AssetsNXGL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • Based on the Altman-Z score of -1.03, we must say that NXGL is in the distress zone and has some risk of bankruptcy.
  • NXGL's Altman-Z score of -1.03 is in line compared to the rest of the industry. NXGL outperforms 43.78% of its industry peers.
  • A Debt/Equity ratio of 0.15 indicates that NXGL is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.15, NXGL is in line with its industry, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z -1.03
ROIC/WACCN/A
WACC9.87%
NXGL Yearly LT Debt VS Equity VS FCFNXGL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

  • A Current Ratio of 1.69 indicates that NXGL should not have too much problems paying its short term obligations.
  • The Current ratio of NXGL (1.69) is worse than 70.81% of its industry peers.
  • A Quick Ratio of 1.08 indicates that NXGL should not have too much problems paying its short term obligations.
  • NXGL has a Quick ratio of 1.08. This is in the lower half of the industry: NXGL underperforms 74.59% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.08
NXGL Yearly Current Assets VS Current LiabilitesNXGL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • NXGL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.33%, which is quite impressive.
  • Looking at the last year, NXGL shows a very strong growth in Revenue. The Revenue has grown by 73.38%.
  • NXGL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 64.56% yearly.
EPS 1Y (TTM)38.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
Revenue 1Y (TTM)73.38%
Revenue growth 3Y77.64%
Revenue growth 5Y64.56%
Sales Q2Q%-0.2%

3.2 Future

  • The Earnings Per Share is expected to grow by 29.14% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 36.74% on average over the next years. This is a very strong growth
EPS Next Y28.6%
EPS Next 2Y37.03%
EPS Next 3Y37%
EPS Next 5Y29.14%
Revenue Next Year37.34%
Revenue Next 2Y39.79%
Revenue Next 3Y41.88%
Revenue Next 5Y36.74%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NXGL Yearly Revenue VS EstimatesNXGL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M
NXGL Yearly EPS VS EstimatesNXGL Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NXGL. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXGL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXGL Price Earnings VS Forward Price EarningsNXGL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXGL Per share dataNXGL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

  • NXGL's earnings are expected to grow with 37.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.03%
EPS Next 3Y37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • NXGL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NEXGEL INC

NASDAQ:NXGL (2/13/2026, 8:00:01 PM)

1.3

-0.01 (-0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11
Earnings (Next)03-23
Inst Owners6.77%
Inst Owner Change-2.63%
Ins Owners13.96%
Ins Owner Change-2.42%
Market Cap10.58M
Revenue(TTM)11.66M
Net Income(TTM)-2.88M
Analysts82.86
Price Target6.12 (370.77%)
Short Float %0.13%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-12.04%
Min EPS beat(2)-26.05%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-5.04%
Min EPS beat(4)-26.05%
Max EPS beat(4)11.76%
EPS beat(8)4
Avg EPS beat(8)-11.18%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.65%
Min Revenue beat(2)-9.08%
Max Revenue beat(2)-8.21%
Revenue beat(4)1
Avg Revenue beat(4)-4.18%
Min Revenue beat(4)-9.08%
Max Revenue beat(4)0.94%
Revenue beat(8)4
Avg Revenue beat(8)-4.41%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-200%
EPS NY rev (1m)0%
EPS NY rev (3m)-25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.91
P/FCF N/A
P/OCF N/A
P/B 2.04
P/tB 3.16
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS1.43
BVpS0.64
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.78%
ROE -55.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.3%
FCFM N/A
ROA(3y)-35.81%
ROA(5y)-46.56%
ROE(3y)-62.13%
ROE(5y)-690.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y266%
GM growth 5YN/A
F-Score6
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.75%
Cap/Sales 0.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.08
Altman-Z -1.03
F-Score6
WACC9.87%
ROIC/WACCN/A
Cap/Depr(3y)166.83%
Cap/Depr(5y)273.19%
Cap/Sales(3y)9%
Cap/Sales(5y)18.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.27%
EPS Next Y28.6%
EPS Next 2Y37.03%
EPS Next 3Y37%
EPS Next 5Y29.14%
Revenue 1Y (TTM)73.38%
Revenue growth 3Y77.64%
Revenue growth 5Y64.56%
Sales Q2Q%-0.2%
Revenue Next Year37.34%
Revenue Next 2Y39.79%
Revenue Next 3Y41.88%
Revenue Next 5Y36.74%
EBIT growth 1Y24.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.13%
EBIT Next 3Y42.97%
EBIT Next 5Y32.41%
FCF growth 1Y35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.73%
OCF growth 3YN/A
OCF growth 5YN/A

NEXGEL INC / NXGL FAQ

What is the ChartMill fundamental rating of NEXGEL INC (NXGL) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NXGL.


What is the valuation status of NEXGEL INC (NXGL) stock?

ChartMill assigns a valuation rating of 1 / 10 to NEXGEL INC (NXGL). This can be considered as Overvalued.


How profitable is NEXGEL INC (NXGL) stock?

NEXGEL INC (NXGL) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for NXGL stock?

The Earnings per Share (EPS) of NEXGEL INC (NXGL) is expected to grow by 28.6% in the next year.